drugset / Trial / NCT01262677

Once-A-Day Pregabalin For Partial Seizures

NCT01262677

Phase 3 Completed 325 enrolled Viatris Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Approximately 30% percent of subjects with partial seizures are refractory to treatment with single or combination antiepileptic drugs. The present study will compare the efficacy of two different dosages of pregabalin CR dosed once daily as compared to placebo, when used as adjunctive therapy in subjects requiring adjunctive therapy for partial onset epilepsy, using a randomized, parallel group design.

Timeline

Start
2011-02-17
Primary completion
2012-07-31
Completion
2012-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 165 mg
Subject Pregabalin Small molecule 330 mg

Indications